Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Download
Standard view
Full view
of .
Look up keyword
Like this
1Activity
0 of .
Results for:
No results containing your search query
P. 1
Emerging Market for Clinical Trials in Brazil

Emerging Market for Clinical Trials in Brazil

Ratings: (0)|Views: 25|Likes:
Scope

The report analyses the clinical trial market in Brazil, along with the major forces driving the current market and the potential challenges that could restrain the growth. The scope of the report includes -
- The need for outsourcing clinical trials to Brazil.
- Trends in clinical trial registration in Brazil and a comparative analysis of clinical trial registration in Brazil, Russia, India and China (BRIC) and six major Latin American countries.
- Analysis of the key drivers that are fueling the growth of the clinical trial market in Brazil.
- Analysis of the key infrastructural facilities, clinical research professionals and principal investigators in Brazil.
- Analysis of key government regulations in Brazil affecting the clinical trial market.
- Study of 13 major CROs operating in Brazil with SWOT analysis of large multinational CROs.
Scope

The report analyses the clinical trial market in Brazil, along with the major forces driving the current market and the potential challenges that could restrain the growth. The scope of the report includes -
- The need for outsourcing clinical trials to Brazil.
- Trends in clinical trial registration in Brazil and a comparative analysis of clinical trial registration in Brazil, Russia, India and China (BRIC) and six major Latin American countries.
- Analysis of the key drivers that are fueling the growth of the clinical trial market in Brazil.
- Analysis of the key infrastructural facilities, clinical research professionals and principal investigators in Brazil.
- Analysis of key government regulations in Brazil affecting the clinical trial market.
- Study of 13 major CROs operating in Brazil with SWOT analysis of large multinational CROs.

More info:

Published by: Fortune Research Reports Private Limited on Jun 29, 2011
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as TXT, PDF, TXT or read online from Scribd
See more
See less

05/20/2012

pdf

text

original

 
Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISAand CONEP are Shortening the Regulatory Approval Process and Advancing the MarketSummaryGBI Research, the leading business intelligence provider, has released its latest report,
Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval Process and Advancingthe Market
which provides key data, information and analysis of the major trendsand issues affecting the clinical trial market in Brazil. The report provides acomprehensive insight of the reasons for outsourcing clinical trials to Brazil and the key services provided by the Clinical Research Organizations (CROs) of Brazil. The report provides a detailed analysis of the Brazilian market in terms of its size, and major service offerings of the CROs in Brazil. The report also discusses the factors that are driving the clinical trial market in Brazil. The report delves into the key documents required by the investigator and the sponsorbefore, during and after the conduct of clinical trials. The report also provides key alliances between the CROs of other countries and the local CROs of Brazil. Furthermore, the report looks into the major challenges that can restrict thegrowth of the clinical trials market in Brazil.for more detail contact here http://www.ordermarketreports.com/product_info.php?products_id=2552website http://www.ordermarketreports.com/1 Table of Contents3 Emerging Market for Clinical Trials, Brazil - Market Overview 114 Emerging Market for Clinical Trials, Brazil - Clinical Trial Trends 265 Emerging Market for Clinical Trials, Brazil - Market Characterization 486 Emerging Market for Clinical Trials, Brazil - Regulatory Landscape 667 Emerging Market for Clinical Trials, Brazil - CRO Landscape 768 Emerging Market for Clinical Trials - Brazil - Appendix 1001.1 List of TablesTable 1: Clinical Trials in Brazil, Global BLA and NME Approvals vs. R&D Spending (bn), 1995-2009 21Table 2: Clinical Trials in Brazil, Global BLA and NME Approvals vs. R&D Spending (bn), 1995-2009 21Table 3: Clinical Trials in Brazil, Global, Drug Patent Expiry ($m), 2010-2017 25Table 4: Clinical Trials in Brazil, Number of Phase l Clinical Trials Registered, 2005-2010 27Table 5: Clinical Trials in Brazil, Number of Phase lI Clinical Trials Registered, 2005-2010 28Table 6: Clinical Trials in Brazil, Number of Phase III Clinical Trials Registered, 2005-2010 29Table 7: Clinical Trials in Brazil, Number of Phase IV Clinical Trials Registered, 2005-2010 30Table 8: Clinical Trials in Brazil, Number of Clinical Trials Registered, BRIC,2010 31
 
Table 9: Clinical Trials in Brazil, Number of Clinical Trials in Six Major Countries of Latin America, 2010 32Table 10: Clinical Trials in Brazil, Distribution of Population among Six MajorCountries of Latin America (%), 2010 33Table 11: Clinical Trials in Brazil, Population Forecast of Brazil (Million), 2005 - 2050 34Table 12: Clinical Trials in Brazil, Comparative Analysis of Industry-sponsoredClinical Trials Registered, BRIC, 2005 - 2010 35Table 13: Clinical Trials in Brazil, Comparative Analysis of Industry-sponsoredClinical Trials Registered, Six Major Countries of Latin America, 2005 - 2010 36Table 14: Clinical Trials in Brazil, Number of Clinical Trials Registered by MNCs in Brazil, 2005 - 2010 37Table 15: Clinical Trials in Brazil, Number of Registered Sites for Industry-sponsored Clinical Trials, Six Major Countries of Latin America, 2005 - 2010 38Table 16: Clinical Trials in Brazil, Number of Multinational Sites for Industry-sponsored Trials (Phase II / III), Six Major Countries of Latin America, 2005 -2010 39Table 17: Clinical Trials in Brazil, Number of Multinational Sites for Industry-sponsored Phase II Trials, Six Major Countries of Latin America, 2008-2010 40Table 18: Clinical Trials in Brazil, Number of Multinational Sites for Industry-sponsored Phase III Trials, Six Major Countries of Latin America, 2008-2010 41Table 19: Clinical Trials in Brazil, Number of Local Sites for Industry-sponsored Trials (Phase II/III), Six Major Countries of Latin America, 2005-2010 42Table 20: Clinical Trials in Brazil, Number of Local Sites for Industry-sponsored Phase II Trials, Six Major Countries of Latin America, 2008 - 2010 43Table 21: Clinical Trials in Brazil, Number of Local Sites for Industry-sponsored Phase III Trials, Six Major Countries of Latin America, 2008 - 2010 44Table 22: Clinical Trials in Brazil, Number of Recruiting Sites by MNCs (%), 2005-2009 45Table 23: Clinical Trials in Brazil, Number of Recruiting Sites for Major Therapeutic Areas, Brazil, 2005-2009 47Table 24: Clinical Trials in Brazil, Global, CRO Market ($bn), 2006-2015 48Table 25: Clinical Trials in Brazil, Number of Local and Multinational Sites inMajor Cities, Brazil, 2005-2009 49Table 26: Clinical Trials in Brazil, Patient Population (Million), 2010 50Table 27: Clinical Trials in Brazil, Number of Deaths by Major Diseases (%), 2008 51Table 28: Clinical Trials in Brazil, Population Forecast for HIV/AIDS (
000), 2010-2015 52Table 29: Clinical Trials in Brazil, Population Forecast for CVD (Million), 2010-2015 53Table 30: Clinical Trials in Brazil, Population Forecast for Diabetes (Million),2010-2015 54Table 31: Clinical Trials in Brazil, Population Forecast for Cancer (
000), 2010-2015 55Table 32: Clinical Trials in Brazil, Average Number of Patients per Trial, BRIC,2005- 2009 56Table 33: Clinical Trials in Brazil, Average Number of Patients per Trial, Six Major Countries of Latin America, 2005- 2009 57Table 34: Clinical Trials in Brazil, Average Number of Patients per Site, BRIC,2005-2009 58Table 35: Clinical Trials in Brazil, Average Number of Patients per Site, Six Major Countries of Latin America, 2005-2009 59Table 36: Clinical Trials in Brazil, Number of Hospitals in Brazil, 2006 60Table 37: Clinical Trials in Brazil, Density of Healthcare Personnel per 10,000Population, 2005 61Table 38: Clinical Trials in Brazil, Number of FDA Regulated Principal Investigators, Brazil, 2001 - 2010 62Table 39: Clinical Trials in Brazil, Growth Rate of Principal Investigators, Global (%), 2002-2008 63
 
Table 40: Clinical Trials in Brazil, Clinical Trial Market, ($m), 2010 - 2015 65Table 41: Clinical Trials in Brazil, Regulatory provisions for Clinical Trials,2011 66Table 42: Clinical Trials in Brazil, Major Documents in Conduction of Clinical Trials, 2011 68Table 43: Clinical Trials in Brazil, Additional Document/Information SubmissionTo The Authorities 70Table 44: Clinical Trials in Brazil, List of Documents Required Before Commencement of Clinical Trials, 2011 72Table 45: Clinical Trials in Brazil, List of Documents Required During Conduction of Clinical Trials, 2011 73Table 46: Clinical Trials in Brazil, List of Documents Required After Completionof Clinical Trials, 2011 74Table 47: Clinical Trials in Brazil, Major Deals in CRO Market, Brail, 2007- 2010 99contact for purchase http://www.ordermarketreports.com/1.2 List of FiguresFigure 1: Clinical Research Process - Overview 11Figure 2: Clinical Trials in Brazil, Parallel Group Trial Design, 2010 13Figure 3: Clinical Trials in Brazil, Cross-over Trial Design, 2010 14Figure 4: Clinical Trials in Brazil, Adaptive Clinical Trial Design, 2010 15Figure 5: Clinical Trials in Brazil, Wyeth Learn and Confirm Model, 2010 17Figure 6: Clinical Trials in Brazil, Services Offered by CROs, 2010 19Figure 7: Clinical Trials in Brazil, Pre-clinical Research to Market Launch ViaClinical Trials, 2009 20Figure 8: Clinical Trials in Brazil, Global BLA and NME Approvals vs. R&D Spending (bn), 1995-2009 21Figure 9: Clinical Trials in Brazil, Activities of R&D Restructuring, 2010 24Figure 10: Clinical Trials in Brazil, Distribution of Clinical Trials by Phase (%), 2010 26Figure 11: Clinical Trials in Brazil, Number of Phase l Clinical Trials Registered, 2005-2010 27Figure 12: Clinical Trials in Brazil, Number of Phase lI Clinical Trials Registered, 2005-2010 28Figure 13: Clinical Trials in Brazil, Number of Phase III Clinical Trials Registered, 2005-2010 29Figure 14: Clinical Trials in Brazil, Number of Phase IV Clinical Trials Registered, 2005-2010 30Figure 15: Clinical Trials in Brazil, Number of Clinical Trials Registered, BRIC, 2010 31Figure 16: Clinical Trials in Brazil, Number of Clinical Trials in Six Major Countries of Latin America, 2010 32Figure 17: Clinical Trials in Brazil, Distribution of Population among Six MajorCountries of Latin America (%), 2010 33Figure 18: Clinical Trials in Brazil, Population Forecast of Brazil (Million), 2005 - 2050 34Figure 19: Clinical Trials in Brazil, Comparative Analysis of Industry-sponsoredClinical Trials Registered, BRIC, 2005 - 2010 35Figure 20: Clinical Trials in Brazil, Comparative Analysis of Industry-sponsoredClinical Trials Registered, Six Major Countries of Latin America, 2005 - 2010 36Figure 21: Clinical Trials in Brazil, Number of Clinical Trials Registered by MNCs in Brazil, 2005 - 2010 37Figure 22: Clinical Trials in Brazil, Number of Registered Sites for Industry-sponsored Clinical Trials, Six Major Countries of Latin America, 2005-2010 38Figure 23: Clinical Trials in Brazil, Number of Multinational Sites for Industry-sponsored Trials (Phase II/III), Six Major Countries of Latin America, 2005 - 2

You're Reading a Free Preview

Download
scribd
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->